Economic burden of chronic obstructive pulmonary disease in Morocco: a cost of illness study

Economic burden of chronic obstructive pulmonary disease in Morocco: a cost of illness study

Chronic obstructive pulmonary disease (COPD) carries an important economic burden worldwide. However, the cost of this disease in Morocco is not well explored. This study aimed to estimate the economic cost associated with COPD in Morocco and identify its determinants. A cost of illness, prevalence...

Full description

Bibliographic Details
Main Authors:	Soumaya Benmaamar, Btissame Es-sabbahi, Mohammed Taghyioullah Haiba, Mohamed Omari, Ibtissam El Harch, Mohammed Youbi, Latifa Belakhhel, Loubna Abousselham, Hafid Hachri, Imane El Menchawyi, Samira EL Fakir, Mohammed Chakib Benjelloun, Nabil Tachfouti
Format:	Article
Language:	English
Published:	PAGEPress Publications 2024-01-01
Series:	Monaldi Archives for Chest Disease
Subjects:	COPD cost severity of COPD tobacco Morocco
Online Access:	https://www.monaldi-archives.org/index.php/macd/article/view/2745

Similar Items

Factors influencing health-related quality of life in patients with chronic obstructive pulmonary disease: insights from the Burden of Obstructive Lung Disease Study in Fez, Morocco
by: Moncef Maiouak, et al.
Published: (2024-10-01)

Measurement Properties of an Arabic Version of the Jefferson Scale of Empathy (JSE) in Moroccan Medical Students
by: SOUMAYA BENMAAMAR, et al.
Published: (2024-01-01)

Knowledge, attitudes, and practices of the ethics in medical research among Moroccan interns and resident physicians
by: Ibtissam El Harch, et al.
Published: (2024-03-01)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
by: Whittaker H, et al.
Published: (2022-03-01)

Assessment of weaning failure in chronic obstructive pulmonary disease patients under mechanical ventilation in Zagazig University Hospitals
by: Adel Hassan A. Ghoneim, et al.
Published: (2017-01-01)

Study of Osteoporosis in chronic obstructive pulmonary disease
by: Ahmad Godah EL-Gazzar, et al.
Published: (2013-01-01)

Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China Pulmonary Health StudyResearch in context
by: Jieping Lei, et al.
Published: (2024-04-01)

Outcomes among patients with chronic obstructive pulmonary disease after recovery from COVID-19 infection of different severity
by: Wang Chun Kwok, et al.
Published: (2024-06-01)

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
by: Anastasia Papaporfyriou, et al.
Published: (2023-05-01)

The role of infectious pathogens in exacerbation of chronic obstructive pulmonary disease in Dakahlia Governorate
by: Elsayed Ahmed Fahmy, et al.
Published: (2020-11-01)

Magnesium Administration For COPD Exacerbation: A Systematic Review and Meta-analysis
by: Hala Alzaid, et al.
Published: (2021-07-01)

A year in the life of German patients with COPD: the DACCORD observational study
by: Buhl R, et al.
Published: (2016-07-01)

Information Needs in COPD After an Educational Programme: Influence in Exacerbations and Admissions
by: Amado CA, et al.
Published: (2020-10-01)

Basal metabolic rate in bronchial asthma and chronic obstructive pulmonary disease patients
by: Mohammed A. Agha, et al.
Published: (2013-01-01)

Estimating the Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Lung Disease
by: Randa Mohammed, et al.
Published: (2022-01-01)

Blood eosinophil variability in patients presenting with acute exacerbations of COPD within the past year and its correlation with treatment plan
by: Samir Mohamed Mahmoud Fahyim, et al.
Published: (2024-03-01)

Evaluation of Inhaler Technique In COPD And Asthma Patients
by: Mohammed Hussein Abdulredha, et al.
Published: (2023-06-01)

Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort
by: Perez-Padilla R, et al.
Published: (2018-10-01)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
by: Miłkowska-Dymanowska J, et al.
Published: (2018-11-01)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
by: Yoon JK, et al.
Published: (2020-08-01)

Management of Refractory Chronic Obstructive Pulmonary Disease: A Review
by: Mandeep Singh Rahi, et al.
Published: (2024-04-01)

Potential pre-COPD indicators in association with COPD development and COPD prediction models in Chinese: a prospective cohort studyResearch in context
by: Jing Fan, et al.
Published: (2024-03-01)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
by: Kwok WC, et al.
Published: (2023-06-01)

The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome
by: Pérez de Llano L, et al.
Published: (2022-03-01)

InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations
by: Dave Singh, et al.
Published: (2021-04-01)

Do 'guidelines' really guide us?
by: Milićević-Nešić Ivana J.
Published: (2017-01-01)

Study of 2-min walk test and 15-step exercise oximetry test in the assessment of exercise tolerance in Egyptian patients with chronic obstructive pulmonary disease
by: Medhat F. Negm, et al.
Published: (2012-10-01)

Integrating the care of the complex COPD patient
by: Claudio F. Donner, et al.
Published: (2017-05-01)

The prognostic value of hypophosphatemia in acute exacerbation of chronic obstructive pulmonary disease (COPD)
by: Ibrahim El-Sayed, et al.
Published: (2017-08-01)

Diaphragmatic assessment in COPD patients by different modalities
by: Amal A. Abd El Aziz, et al.
Published: (2017-04-01)

Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol
by: Trishul Siddharthan, et al.
Published: (2018-10-01)

Serum Troponin-I as a prognostic marker in acute exacerbated chronic obstructive pulmonary disease patients
by: Abdel Rahim I. Youssef, et al.
Published: (2013-10-01)

Study of mannose-binding lectin in smokers with and without COPD
by: Maha M. Naguib, et al.
Published: (2015-04-01)

Study the relationship of erythropoietin and chronic obstructive pulmonary disease
by: R.I. El-Korashy, et al.
Published: (2012-07-01)

Is there a role for cough peak flow in assessment of patients with severe COPD?
by: Sherouk El Batrawy, et al.
Published: (2014-10-01)

Editorial: Future research questions for improving COPD diagnosis and care
by: Ahmed S. Sadaka, et al.
Published: (2024-04-01)

Low cost biological lung volume reduction therapy for advanced emphysema
by: Bakeer M, et al.
Published: (2016-08-01)

Assessment of hyaluronic acid in COPD patients as a prognostic biomarker
by: Marwa Elsayed Elnaggar, et al.
Published: (2024-03-01)

A double‐blind randomized controlled trial of N‐acetylcysteine (NAC) for the treatment of acute exacerbation of chronic obstructive pulmonary disease
by: Wang Chung Kwok, et al.
Published: (2024-08-01)

A mRNA panel for differentiation between acute exacerbation or pneumonia in COPD patients
by: Wilhelm Bertrams, et al.
Published: (2024-03-01)